PhP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
type: AdministrableProductDefinition
node role: treeRoot
id:
  v: PhP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
meta:
  profile:
    v: http://fhir.ch/ig/ch-idmp/StructureDefinition/ch-idmp-administrableproductdefinition
    l: ch-idmp-administrableproductdefinition
text:
  status:
    v: generated
  div:
    v: Generated Narrative: AdministrableProductDefinition PhP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet Profile: AdministrableProductDefinition status: Active formOf: MedicinalProductDefinition: extension = Film-coated tablet; identifier = http://fhir.ch/ig/ch-idmp/sid/mpid#Medical Product Identifier#CH-01100869-0672110010000; indication = Xospata wird angewendet für die Behandlung von erwachsenen Patienten, die an rezidivierter oder refraktärer akuter myeloider Leukämie (AML) mit FMS-ähnlichen Tyrosinkinase 3 (FLT3)-Mutationen leiden.; legalStatusOfSupply = A: Single dispensing requiring a medical or veterinary prescription; additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = gilteritinib,Synthetic administrableDoseForm: Film-coated tablet unitOfPresentation: Tablet RouteOfAdministrations - Code * Oral use
status:
  v: active
form of:
  l: Xospata-Filmcoatedtablet
  reference:
    v: MedicinalProductDefinition/Xospata-Filmcoatedtablet
administrable dose form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 10221000
    display:
      v: Film-coated tablet
unit of presentation:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 15054000
    display:
      v: Tablet
route of administration:
  code:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use